| All ( n = 35) | Community-associated (n = 23) | Hospital-associated (n = 12) | p-value |
---|---|---|---|---|
Clinical findings | ||||
APACHE II score, median (range) | 15 (4–46) | 12 (4–46) | 19 (6–30) | 0.55 |
Headache (%) | 4 (11.4) | 3 (13) | 1 (8.3) | 1.0 |
Nausea (%) | 3 (8.6) | 1 (4.3) | 2 (16.7) | 0.27 |
Reduced consciousness (%) | 11 (31.4) | 6 (26.1) | 5 (41.7) | 0.45 |
Seizure (%) | 6 (17.1) | 3 (13) | 3 (25) | 0.39 |
Focal neurologic (%) | 3 (8.6) | 2 (8.7) | 1 (8.3) | 1.0 |
Diarrhea (%) | 3 (8.6) | 2 (8.7) | 1 (8.3) | 1.0 |
Fever (%) | 31 (88.6) | 20 (87) | 11 (91.7) | 1.0 |
Adequate antibiotic therapy within 24Â hours (%) | 4 (11.4) | 1 (4.3) | 3 (25) | 0.16 |
CNS infection (%) | 10 (28.6) | 8 (34.8) | 2 (16.7) | 0.43 |
60-day mortality (%) | 12 (34.3) | 4 (17.4) | 8 (66.7) | 0.01 |
Hospital duration, median day (range) | 28 (1–126) | 20 (1–124) | 53 (15–126) | 0.01 |
Laboratory findings | ||||
ALT, median IU/L (range) | 41 (6–248) | 47.5 (6–248) | 39 (15–177) | 0.88 |
Total bilirubin, median mg/dL (range) | 0.9 (0.2–7.9) | 0.8 (0.2–4) | 0.5 (0.2–7.9) | 0.24 |
Albumin, median g/dL (range) | 2.7 (1.4–3.9) | 2.6 (1.7–3.8) | 2.4 (1.4–3.9) | 0.93 |
White blood cells, median 109/L (range) | 8.38 (0.19–28.16) | 13.39 (3.36–27.47) | 8.38 (0.19–28.16) | 0.06 |
Platelets, median /mm3 (range) | 117 (4–350) | 158.72 (27.7–350) | 101.91 (4–275) | 0.18 |
Serum creatinine, median mg/dL (range) | 1.1 (0.4–17.2) | 1.10 (0.58–17.2) | 1.10 (0.4–8.84) | 0.07 |
Site of L. monocytogenes isolates | Â | Â | Â | Â |
Blood (%) | 33 (94.3) | 21 (91.3) | 12 (100) | 0.54 |
CSF (%) | 6 (17.1) | 5 (21.7) | 1 (8.3) | 0.64 |
Joint fluid (%) | 1 (2.8) | 1 (4.3) | 0 (0) | 1.0 |